← back to search

Vijay Ramaswamy

Cancer Clinic · CA
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Hedgehog Signaling Pathway Studies, Neuroblastoma Research and Treatments, and Chromatin Remodeling and Cancer.
h-index
75
citations
27,252
works
656
NIH funding
primary concept
Medulloblastoma
email

Recent publications

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Cancer Cell 2025cited by 14position: middledoi
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip
Nature Genetics 2025cited by 11position: middledoi
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
medRxiv 2025cited by 5position: middledoi
An international study presenting a federated learning AI platform for pediatric brain tumors
Nature Communications 2024cited by 35position: middledoi
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Neuro-Oncology 2024cited by 23position: middledoi
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201
Journal of Clinical Oncology 2024cited by 11position: middledoi
Distinct relapse pattern across molecular ependymoma types
Neuro-Oncology 2024cited by 7position: middledoi
A telerehabilitation program to improve visual perception in children and adolescents with hemianopia consecutive to a brain tumor: a single-arm feasibility and proof-of-concept trial
EClinicalMedicine 2024cited by 7position: middledoi
EPEN-01. DISTINCT RELAPSE PATTERN ACROSS MOLECULAR EPENDYMOMA TYPES
Neuro-Oncology 2024cited by 2position: middledoi
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
Cancer Discovery 2023cited by 44position: middledoi
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
Neuro-Oncology 2023cited by 41position: middledoi
Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome
Neuro-Oncology 2023cited by 20position: middledoi
Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance
Neuro-Oncology 2023cited by 9position: middledoi
A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial<i>ZFTA-</i>fused ependymoma
Neuro-Oncology Advances 2023cited by 8position: middledoi
MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study
Radiology 2022cited by 73position: middledoi
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors
Nature Communications 2022cited by 33position: middledoi
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study
Journal of Clinical Oncology 2022cited by 28position: middledoi
Recurrent ACVR1 mutations in posterior fossa ependymoma
Acta Neuropathologica 2022cited by 18position: middledoi
MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
Neuro-Oncology 2022cited by 1position: middledoi
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion–Positive Supratentorial Ependymomas
Cancer Discovery 2021cited by 109position: middledoi
The transcriptional landscape of Shh medulloblastoma
Nature Communications 2021cited by 94position: middledoi
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
Journal of Clinical Oncology 2021cited by 84position: middledoi
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Neuro-Oncology 2021cited by 82position: lastdoi
Subgroup and subtype-specific outcomes in adult medulloblastoma
Acta Neuropathologica 2021cited by 78position: lastdoi
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
Neuro-Oncology 2021cited by 52position: middledoi
Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles
Neuro-Oncology 2021cited by 22position: middledoi
Machine Assist for Pediatric Posterior Fossa Tumor Diagnosis: A Multinational Study
Neurosurgery 2021cited by 19position: middledoi
EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
Neuro-Oncology 2021cited by 0position: middledoi
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Nature Medicine 2020cited by 241position: middledoi
Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
Cell 2020cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael D. Taylor · Norcliffe Foundation30 papers (2013–2021)Stefan M. Pfister · Université du Québec21 papers (2013–2024)Marc Remke · Saarland University15 papers (2013–2019)Marcel Kool · European Bioinformatics Institute14 papers (2013–2021)Éric Bouffet · Université Laval13 papers (2013–2024)Andrey Korshunov · German Cancer Research Center13 papers (2013–2021)Paul A. Northcott · Children's Research Hospital10 papers (2013–2020)David Jones · Mayo Clinic in Florida9 papers (2013–2020)Cynthia Hawkins · Université Laval7 papers (2013–2022)Stefan Rutkowski · Universität Hamburg7 papers (2013–2024)Uri Tabori · Occupational Cancer Research Centre6 papers (2013–2024)Florence M.G. Cavalli · Institut Curie6 papers (2013–2020)Giles Robinson · Children's Research Hospital5 papers (2016–2024)Nada Jabado · McGill University Health Centre5 papers (2013–2024)Steven C. Clifford · Center for Cancer Research5 papers (2016–2020)Volker Hovestadt · Harvard University5 papers (2013–2020)Martin Sill · German Cancer Research Center5 papers (2015–2020)Amar Gajjar · Mills Peninsula Health Services5 papers (2016–2024)David W. Ellison · Children's Research Hospital4 papers (2015–2021)Hendrik Witt · German Cancer Research Center4 papers (2013–2017)